FFA
ARKG icon

Farther Finance Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Farther Finance Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.9K Buy
1,566
+727
+87% +$23.2K ﹤0.01% 3031
2026
Q1 		$22.7K Sell
839
-100
-11% -$2.93K ﹤0.01% 3569
2025
Q4 		$27.2K Buy
939
+9
+1% +$270 ﹤0.01% 3226
2025
Q3 		$25.8K Buy
930
+265
+40% +$6.7K ﹤0.01% 2864
2025
Q2 		$16.2K Sell
665
-34
-5% -$745 ﹤0.01% 2806
2025
Q1 		$14.1K Buy
699
+409
+141% +$10.3K ﹤0.01% 2562
2024
Q4 		$6.83K Sell
290
-10,360
-97% -$255K ﹤0.01% 2536
2024
Q3 		$273K Sell
10,650
-222
-2% -$5.65K 0.01% 870
2024
Q2 		$253K Buy
10,872
+1,481
+16% +$37.4K 0.01% 738
2024
Q1 		$266K Buy
9,391
+2,783
+42% +$83.7K 0.02% 589
2023
Q4 		$217K Buy
6,608
+4,680
+243% +$127K 0.02% 531
2023
Q3 		$53.7K Hold
1,928
– – 0.01% 751
2023
Q2 		$65.7K Hold
1,928
– – 0.01% 581
2023
Q1 		$58K Hold
1,928
– – 0.02% 569
2022
Q4 		$54.4K Buy
+1,928
New +$61.2K 0.02% 467

Other funds holding ARKG

MFPI
Midwest Financial Partners Investments St. Cloud, Minnesota $241M AUM
CIC
Canal Insurance Company Greenville, South Carolina $456M AUM 40.11% 1-Year Est. Return
CFIM
Client First Investment Management West Bend, Wisconsin $237M AUM 90.28% 1-Year Est. Return
BCM
Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
PWM
Purus Wealth Management Newport Beach, California $363M AUM 39.16% 1-Year Est. Return
LW
Lauer Wealth Valparaiso, Indiana $167M AUM 23.59% 1-Year Est. Return

Farther Finance Advisors's ARKG Position: Q2 2026 in Review

Farther Finance Advisors increased its ARK Genomic Revolution ETF (ARKG) stake by 87% in Q2 2026, buying an estimated $23.2K and bringing the position to 1,566 shares worth $65.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3031.

Farther Finance Advisors first reported a position in ARKG in Q4 2022 and has held it in 15 quarters since. The position peaked at $273K in Q3 2024. 54 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Farther Finance Advisors held 1,566 shares of ARK Genomic Revolution ETF worth $65.9K as of Q2 2026.
  • Farther Finance Advisors bought 727 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $23.2K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3031 holding.
  • Farther Finance Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's ARK Genomic Revolution ETF position peaked at $273K in Q3 2024.
  • 54 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.